publication venue for
- A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer. 70:3451-3460. 2021
- Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells. 67:575-587. 2018
- Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial. 61:2033-2044. 2012
- Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination. 61:2105-2112. 2012
- Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production. 60:381-388. 2011
- Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cells. 59:313-321. 2010
- Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: Identification of transforming growth factor-β as a suppressive factor. 32:296-302. 1991
- Characterization of human malignant melanoma cell lines. III. Membrane immunofluorescence reactivity with sera from patients with melanoma. 3:239-246. 1978
- Fine analysis of spontaneous and vaccine-induced immune responses to the broadly-expressed cancer-testis antigen, NY-ESO-1 2007